Novartis AG (NVS)
159.98
-3.12
(-1.91%)
USD |
NYSE |
Sep 04, 16:00
152.44
-7.54
(-4.71%)
After-Hours: 20:00
Novartis Cash and Short Term Investments (Annual) : 11.59B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 11.59B |
| December 31, 2024 | 13.46B |
| December 31, 2023 | 14.43B |
| December 31, 2022 | 18.93B |
| December 31, 2021 | 28.33B |
| December 31, 2020 | 11.56B |
| December 31, 2019 | 11.45B |
| December 31, 2018 | 15.95B |
| December 31, 2017 | 9.485B |
| December 31, 2016 | 7.777B |
| December 31, 2015 | 5.447B |
| December 31, 2014 | 13.86B |
| December 31, 2013 | 9.222B |
| December 31, 2012 | 8.119B |
| December 31, 2011 | 5.075B |
| December 31, 2010 | 8.152B |
| December 31, 2009 | 17.45B |
| Date | Value |
|---|---|
| December 31, 2008 | 6.117B |
| December 31, 2007 | 13.20B |
| December 31, 2006 | 7.955B |
| December 31, 2005 | 10.93B |
| December 31, 2004 | 13.93B |
| December 31, 2003 | 13.29B |
| December 31, 2002 | 12.24B |
| December 31, 2001 | 13.16B |
| December 31, 2000 | 12.66B |
| December 31, 1999 | 10.20B |
| December 31, 1998 | 9.710B |
| December 31, 1997 | 12.67B |
| December 31, 1996 | 14.18B |
| December 31, 1995 | 13.36B |
| December 31, 1994 | 9.617B |
| December 31, 1993 | 9.034B |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Roche Holding AG | 19.53B |
| AstraZeneca PLC | 5.741B |
| Johnson & Johnson | 20.10B |
| Eli Lilly & Co. | 7.268B |
| Merck & Co., Inc. | 14.69B |